Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juvista in Ear Lobe Keloids
NCT00469235Phase 2Completed
- Sponsor
- Renovo
- Start
- Jun 2007
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of avotermin in keloid (2 arms), sponsored by Renovo. Primary endpoint: Frequency of adverse events at 3 months. Started Jun 2007; status: completed.
02
Drugs
avotermin
03
Conditions
keloid
Beyond the preview
Go deeper on NCT00469235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469235.